Results from a Phase I Clinical Trial of HBED
- 1 January 1994
- book chapter
- Published by Springer Nature
- Vol. 356, 351-359
- https://doi.org/10.1007/978-1-4615-2554-7_37
Abstract
The experience of the past dozen years clearly indicates that iron plays a significant role in the pathogenesis of a wide variety of disease states apart from hemochromatosis. 1 In cases of rheumatoid arthritis and reperfusion injury, iron catalyzes the formation of free radicals which destroy membranes and thereby lead to tissue damage. Sequestration of this iron would obviate much of this damage. In lymphopro-liferative disorders and parasitic diseases such as malaria, iron serves as an essential nutrient for dividing cells. Withholding iron would inhibit cell division and hence slow the progression of such diseases. While unlikely to affect cures, chelation of iron would undoubtedly be of benefit as adjunctive therapy in these and related disorders.Keywords
This publication has 16 references indexed in Scilit:
- Iron chelators in medicineMolecular Aspects of Medicine, 1992
- Synthesis and biological evaluation of hydroxamate-based iron chelatorsJournal of Medicinal Chemistry, 1991
- Evaluation of desferrithiocin and its synthetic analogs as orally effective iron chelatorsJournal of Medicinal Chemistry, 1991
- The Development of Hydroxypyridin‐4‐ones as Orally Active Iron ChelatorsAnnals of the New York Academy of Sciences, 1990
- Pyridoxal Isonicotinoyl HydrazoneAnnals of the New York Academy of Sciences, 1990
- HBED: A Potential Oral Iron ChelatoraAnnals of the New York Academy of Sciences, 1990
- Current Therapy of Cooley's Anemia.Annals of the New York Academy of Sciences, 1990
- L1 (1,2‐dimethyl‐3‐hydroxypyrid‐4‐one) for oral iron chelation in patients with beta‐thalassaemia majorBritish Journal of Haematology, 1990
- Evaluation of the Oral Iron Chelator 1,2-Dimethyl-3-hydroxypyrid-4-one (L1) in Iron-Loaded PatientsAnnals of the New York Academy of Sciences, 1990
- High Molecular Weight Forms of Deferoxamine: Novel Therapeutic Agents for Treatment of Iron-Mediated Tissue InjuryPublished by Springer Nature ,1990